These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 31651280

  • 1. The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer.
    Lu Y, Ma L, Qin J, Wang Z, Guo J, Zhao Y, Zhang H, Yan X, Liu H, Li H, Kamel IR, Qu J.
    BMC Cancer; 2019 Oct 24; 19(1):999. PubMed ID: 31651280
    [Abstract] [Full Text] [Related]

  • 2. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D, Drago SG, Pecorelli A, Maino C, Querques G, Mariani I, Franzesi CT, Sironi S.
    World J Gastroenterol; 2020 May 28; 26(20):2657-2668. PubMed ID: 32523318
    [Abstract] [Full Text] [Related]

  • 3. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
    Zou HH, Yu J, Wei Y, Wu JF, Xu Q.
    J Magn Reson Imaging; 2019 Mar 28; 49(3):885-893. PubMed ID: 30079601
    [Abstract] [Full Text] [Related]

  • 4. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
    Palmisano A, Esposito A, Rancoita PMV, Di Chiara A, Passoni P, Slim N, Campolongo M, Albarello L, Fiorino C, Rosati R, Del Maschio A, De Cobelli F.
    Clin Radiol; 2018 Oct 28; 73(10):911.e1-911.e7. PubMed ID: 30029837
    [Abstract] [Full Text] [Related]

  • 5. Value of perfusion parameters from golden-angle radial sparse parallel dynamic contrast-enhanced magnetic resonance imaging in predicting pathological complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Pan YN, Gu MY, Mao QL, Wei YG, Zhang L, Tang GY.
    Diagn Interv Radiol; 2024 Jul 08; 30(4):228-235. PubMed ID: 38528760
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy.
    Heethuis SE, van Rossum PS, Lips IM, Goense L, Voncken FE, Reerink O, van Hillegersberg R, Ruurda JP, Philippens ME, van Vulpen M, Meijer GJ, Lagendijk JJ, van Lier AL.
    Radiother Oncol; 2016 Jul 08; 120(1):128-35. PubMed ID: 27296409
    [Abstract] [Full Text] [Related]

  • 9. DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer.
    Qu J, Ma L, Lu Y, Wang Z, Guo J, Zhang H, Yan X, Liu H, Kamel IR, Qin J, Li H.
    Discov Oncol; 2022 Jan 08; 13(1):3. PubMed ID: 35201487
    [Abstract] [Full Text] [Related]

  • 10. Multidetector CT for Restaging Locally Advanced Esophageal Squamous Cell Carcinoma and Assessing Therapeutic Response to Neoadjuvant Chemotherapy.
    Shi Y, Chen Y, Li X, Wang Z, Sun Y.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb 20; 39(1):133-139. PubMed ID: 28270296
    [Abstract] [Full Text] [Related]

  • 11. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
    Petrillo A, Fusco R, Petrillo M, Granata V, Delrio P, Bianco F, Pecori B, Botti G, Tatangelo F, Caracò C, Aloj L, Avallone A, Lastoria S.
    Oncotarget; 2017 Jan 31; 8(5):8143-8153. PubMed ID: 28042958
    [Abstract] [Full Text] [Related]

  • 12. Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC.
    Petrillo A, Fusco R, Petrillo M, Granata V, Sansone M, Avallone A, Delrio P, Pecori B, Tatangelo F, Ciliberto G.
    Eur Radiol; 2015 Jul 31; 25(7):1935-45. PubMed ID: 25577525
    [Abstract] [Full Text] [Related]

  • 13. [Predictive value of quantitative dynamic contrast-enhanced magnetic resonance imaging for the efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer].
    Zhu YJ, Li Y, Jiang J, Zhang W, Xue LY, Zhou AP, Jiang LM.
    Zhonghua Zhong Liu Za Zhi; 2019 Oct 23; 41(10):765-770. PubMed ID: 31648499
    [Abstract] [Full Text] [Related]

  • 14. [Study on the relationship between tumor regression grade and lymph node regression grade].
    Zhao Q, Fu C, Yu E, Zhang W, Meng R, Wang H, Hao L, Wang H.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep 25; 20(9):1050-1054. PubMed ID: 28900999
    [Abstract] [Full Text] [Related]

  • 15. Dynamic contrast-enhanced and diffusion-weighted MR imaging in early prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    Li J, Yan LL, Zhang HK, Wang Y, Xu SN, Li HL, Qu JR.
    Abdom Radiol (NY); 2022 Oct 25; 47(10):3394-3405. PubMed ID: 35916943
    [Abstract] [Full Text] [Related]

  • 16. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
    Zheng D, Lai G, Chen Y, Yue Q, Liu X, Chen X, Chen W, Chan Q, Chen Y.
    J Magn Reson Imaging; 2018 Nov 25; 48(5):1208-1216. PubMed ID: 29693765
    [Abstract] [Full Text] [Related]

  • 17. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer.
    Intven M, Monninkhof EM, Reerink O, Philippens ME.
    Acta Oncol; 2015 Nov 25; 54(10):1729-36. PubMed ID: 25914930
    [Abstract] [Full Text] [Related]

  • 18. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Miccichè F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):752-60. PubMed ID: 15936556
    [Abstract] [Full Text] [Related]

  • 19. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer.
    Petrillo A, Fusco R, Petrillo M, Granata V, Bianco F, Di Marzo M, Delrio P, Tatangelo F, Botti G, Pecori B, Avallone A.
    Jpn J Radiol; 2018 Oct 01; 36(10):611-621. PubMed ID: 30039258
    [Abstract] [Full Text] [Related]

  • 20. Spectral CT vs. diffusion-weighted imaging for the quantitative prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    Li J, Xu S, Wang Y, Ma F, Chen X, Qu J.
    Eur Radiol; 2024 Sep 01; 34(9):6193-6204. PubMed ID: 38345605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.